WebSite > Shenzhen Excellent Biomedical Technology Co., Ltd.

Shenzhen Excellent Biomedical Technology Co., Ltd.

  • Company Name Shenzhen Excellent Biomedical Technology Co., Ltd.
  • Tel 0755-26050679
  • Email 2850803126@qq.com
  • WebSite www.ex-biotech.com/
  • CB Index 58
  •       ShenZhen Excellent Biomedical Technology Co., Ltd. (SZEB) is a high-tech enterprise specializing in pharmaceutical impurity reference standards and services for drug R&D institutions and manufacturers. We had provided professional products and services for more than 5000 pharmaceutical companies and scientific research institutions, and have maintained long-term cooperative relationships with many well-known pharmaceutical companies and institutions, such as Yangtze River Pharmaceutical Group、QiLu Pharmaceutical、CSPC Pharmaceutical Group Co.,Ltd.、Leading Pharm Medical Technology、Baiyunshan Pharmaceutical 、ShanDong Lukang Pharmaceutical Co.,Ltd. ,which makes us the best partner for pharmaceutical impurity research. As the national high-tech enterprise ,SZEB has attained the prestigious ISO9001 international quality certification,and has been recognised as an innovative enterprise、science and technology-based enterprise .
Shenzhen Excellent Biomedical Technology Co., Ltd. Product List
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name Azilsartan
  • MF C25H20N4O5
  • CAS 147403-03-0
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name Folic Acid
  • MF C19H19N7O6
  • CAS 59-30-3
  •  
  •  
  •  
  •  
  • Product Name Fluticasone
  • MF C22H27F3O4S
  • CAS 90566-53-3
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •